$0.7553
0.056.38%
At close: -
$0.7130
-0.04-5.60%
After Hours: Apr 9, 5:21 AM EDT
Comments
Loading...
Barinthus Biotherapeutics Stock Price, Quotes and Forecasts
BRNSNASDAQ
Barinthus Biotherapeutics (BRNS) Forecast
NewsEarningsBarinthus Biotherapeutics (BRNS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Barinthus Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:BRNS | Benzinga
Explore Barinthus Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BRNS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Barinthus Biotherapeutics (BRNS) stock?
You can purchase shares of Barinthus Biotherapeutics (NASDAQ:BRNS) through any online brokerage.
Who are Barinthus Biotherapeutics (BRNS) competitors?
Other companies in Barinthus Biotherapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Intensity Therapeutics (NASDAQ:INTS), Burning Rock Biotech (NASDAQ:BNR) and Aligos Therapeutics (NASDAQ:ALGS).
What is the forecast, or price target, for Barinthus Biotherapeutics (BRNS) stock?
Barinthus Biotherapeutics has a consensus price target of $5.17.
What is the current price for Barinthus Biotherapeutics (BRNS)?
The stock price for Barinthus Biotherapeutics (NASDAQ: BRNS) is $0.713 last updated April 9, 2025 at 5:21 AM EDT.
Does Barinthus Biotherapeutics (BRNS) pay a dividend?
There are no upcoming dividends for Barinthus Biotherapeutics.
When is Barinthus Biotherapeutics (NASDAQ:BRNS) reporting earnings?
Barinthus Biotherapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Barinthus Biotherapeutics (BRNS) going to split?
There is no upcoming split for Barinthus Biotherapeutics.
What sector and industry does Barinthus Biotherapeutics (BRNS) operate in?
Barinthus Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
